Arca
Skip to content
Tools
Tools

Dermatan sulfate

Oligosaccharide in Homo sapiens that 4 drugs act on.

  • Drugs that act on it: 4
  • Approved: 2
  • In phases 1 to 3: 2
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 4

Approved2

  • Laronidase
  • Galsulfase

Phase 32

  • Idursulfase beta
  • Pabinafusp alfa

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • JCR Pharmaceuticals Co., Ltd.125%

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Dermatan sulfate hydrolytic enzyme.
      LaronidaseBoxed warningApprovedBioMarin PharmaceuticalProtein or peptideHydrolytic enzyme2
      GalsulfaseBoxed warningApprovedBioMarin PharmaceuticalProtein or peptideHydrolytic enzyme1
      Idursulfase betaPhase 3Green CrossProtein or peptideHydrolytic enzyme0
      Pabinafusp alfaPhase 3JCR Pharmaceuticals Co., Ltd.Protein or peptideHydrolytic enzyme0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 2 in all, from ClinicalTrials.gov.
      Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.Laronidase—Active, not recruitingMasonic Cancer Center, University of MinnesotaDec 2, 2022
      PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)Galsulfase, LaronidasePhase 1RecruitingUniversity of California, San FranciscoAug 31, 2020

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364179, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.